Bank of America’s Galera Therapeutics, Inc. Common Stock GRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding GRTX
GCP
NFGH
AI
Bank of America's GRTX Position: Q1 2024 in Review
Bank of America sold out of Galera Therapeutics, Inc. Common Stock (GRTX) in Q1 2024, closing a stake of 500 shares — an estimated $72 sold.
Bank of America first reported a position in GRTX in Q4 2019 and held it in 17 quarters. The position peaked at $291K in Q4 2020. 36 funds tracked by Wall St. Rank hold GRTX as of Q1 2024.
- Bank of America reported no remaining Galera Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
- Bank of America sold 500 Galera Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $72.
- Bank of America first reported a position in Galera Therapeutics, Inc. Common Stock in Q4 2019 and held it in 17 quarters.
- Bank of America's Galera Therapeutics, Inc. Common Stock position peaked at $291K in Q4 2020.
- 36 funds tracked by Wall St. Rank held Galera Therapeutics, Inc. Common Stock as of Q1 2024.
Based on Bank of America's 13F filing for Q1 2024, filed 15 May 2024.